Apotex is Canada's largest pharmaceutical company with global operations spanning API manufacturing, finished dosage form production, and CDMO/co-development services. With capacity to produce approximately 25 billion finished doses annually and three API manufacturing sites, they serve both their own generic portfolio and external partners through Apotex Pharmachem (API CDMO) and Apotex Fermentation (fermentation-based manufacturing).
generic pharmaceutical manufacturing, API manufacturing (chemical synthesis and fermentation), co-development services, finished dosage form production, 25 billion dose annual capacity, immuno-oncology (toripalimab/LOQTORZI)
3 sites worldwide
No reviews available yet.
No documents available.